Company

HOPO Therapeutics

Biotechnology Research San Francisco Bay Area, United States 13 employees

Employees: 13
Contacts: 3
Emails: 3

www.hopotx.com LinkedIn

HOPO Therapeutics Overview

Headquarters: San Francisco Bay Area, United States
Website: www.hopotx.com
Industry: Biotechnology Research
Employees: 13
Founded: 2020
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Women's and Children's Health Global Environmental Health Lead Poisoning Heavy Metal Toxicity Health Security Oncology Radioligand Therapy

About HOPO Therapeutics

HOPO Therapeutics is a privately-held, clinical-stage pharmaceutical company developing treatments for heavy metal poisoning and pioneering novel methods for directed radioisotope delivery. Leveraging world-class expertise in the chemistry and biochemistry of heavy metals and technology licensed from Lawrence Berkeley National Laboratory, HOPO’s mission is to safeguard all people throughout the world from the harmful effects of heavy metal contamination while utilizing the power of metals in medicine to cure disease and improve lives.

HOPO Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

HOPO Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Julian Rees	CEO & Co-founder of Hopo Therapeutics	San Francisco Bay Area, United States	Email
Sharlene Tingin		Berkeley, California, United States	View
Josh Godshaw	Analytical Chemist - Data Enthusiast	San Francisco, California, United States	Email
Kris Vulgan	Managing Gp Ferocity Capital	San Francisco Bay Area, United States	Email